NDC 0074-7401

Depakote ER

Divalproex Sodium

Depakote ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Divalproex Sodium.

• Product ID: 0074-7401_700d612c-c97c-48e2-8183-91cc42b9069e
• NDC: 0074-7401
• Product Type: Human Prescription Drug
• Proprietary Name: Depakote ER
• Generic Name: Divalproex Sodium
• Dosage Form: Tablet, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2000-08-04
• Marketing Category: NDA /
• Application Number: NDA021168
• Labeler Name: AbbVie Inc.
• Substance Name: DIVALPROEX SODIUM
• Active Ingredient Strength: 250 mg/1
• Pharm Classes: Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0074-7401-13

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-7401-13)

• Marketing Start Date: 2000-08-04
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Depakote ER" or generic name "Divalproex Sodium"

NDC	Brand Name	Generic Name
70518-1758	Depakote ER	Depakote ER
70518-1759	Depakote ER	Depakote ER
43353-310	Depakote ER	Depakote ER
63629-3370	Depakote ER	Depakote ER
0074-3826	Depakote	Divalproex Sodium
0074-6114	Depakote	Divalproex Sodium
0074-6212	Depakote	Divalproex Sodium
0074-6214	Depakote	Divalproex Sodium
0074-6215	Depakote	Divalproex Sodium
0074-7126	Depakote	Divalproex Sodium